Via The Guardian, an August 12 report by The Associated Press: Ebola: Liberia says experimental drug on the way from US.
Liberia has announced it is to receive doses of an experimental Ebola drug and give it to two sick doctors, making them the first Africans to receive some of the scarce treatment in a spiralling outbreak.
The US government confirmed that it had put Liberian officials in touch with the maker of ZMapp and referred additional questions to the manufacturer. In a statement, the California-based Mapp Biopharmaceutical said that in responding to a request from an unidentified west African country it had run out of its supply of the treatment.
The news came amid growing anger over the fact that the only people to receive the experimental treatment so far had been westerners: two Americans and a Spaniard, all of whom were evacuated to their home countries from Liberia.
On Monday the World Health Organisation said 1,013 people had died in the Ebola outbreak in west Africa. Authorities had recorded 1,848 suspected, probable or confirmed cases of the disease, the UN health agency said. The updated WHO tally includes figures from 7-9 August when 52 more people died and 69 more were infected.
There is no Ebola vaccine or treatment available but there are several in development besides ZMapp. That treatment is so new that it has not been tested for safety or effectiveness in humans. The company has said it would take months to produce even modest quantities.
It was unclear how much of the treatment would be sent to Liberia.
The Liberian statement, posted on the presidency’s website, said it was also receiving an experimental treatment from the World Health Organisation. It was unclear if this was referring to ZMapp or another treatment.